Clinical Trial

Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma

Study acronym: SWEMMA
Recruiting
View on ClinicalTrials.gov →
Summary
The SWEMMA trial is an open, national, multi-center, prospective, randomized (1:1), superiority trial designed to assess impact on reoperation rates for chronic subdural hematoma with a head-to-head comparison of embolization of the middle meningeal artery (intervention) with standard neurosurgical hematoma evacuation (control).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-24; most recent amendment 2024-04-08.
Status change: Not Yet Recruiting → Recruiting 2022-04-22
Trial Details
NCT Number NCT05267184
Lead Sponsor Region Skane
Collaborators: Lund University, Sahlgrenska University Hospital, Karolinska University Hospital, Norrlands University Hospital
Conditions Chronic Subdural Hematoma
Enrollment 288 participants
Start Date 2022-03-28
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2024-04-09